| BCRX Snapshot | |
|---|---|
| BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina. | |
| VALUATION DATA | |
| Market Capitalization | $843,154,000 | Price to Sales | 2.00 |
| Earnings per Share | $-1.1800 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $4.1600 |
| 52 Week High | $2.967 |
| 52 Week Low | $56.59 |
| 50-Day Moving Average | $4.283 |
| 200-Day Moving Average | $-12.2 |
| All data are from Alpha Vantage as of today. For more infomation on BCRX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search